Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments
  • Print
  • Share
  • E-mail
-
1 to 8 of 8 Results
Document Number K060738
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas c 303  {ONLINE TDM N-acetylprocainamide} 
CR220437 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 12/19/2022
Roche Diagnostics cobas c 503 analytical unit  
CR200089 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 03/18/2020
Roche Diagnostics cobas c 502 Analyzer  
K100853 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 01/10/2011
Roche Diagnostics cobas c 311 Analyzer  
K060738 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 01/22/2008
Roche Diagnostics Hitachi 911  
K060738 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 11/22/2006
Roche Diagnostics Hitachi 912  
K060738 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 11/22/2006
Roche Diagnostics Hitachi Modular P  
K060738 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 11/22/2006
Roche Diagnostics Hitachi 917  
K060738 K060738 N-acetylprocainamide (NAPA) Toxicology / TDM MODERATE 08/16/2006

-
-